Particulate Matter From Syringes Used for Intravitreal Injections

Related

• 

  Endophthalmitis After Intravitreal Injections with 0.05% Aqueous Chlorhexidine vs 5% Povidone-Iodine as Ocular Antiseptics

  Murtaza K Adam, MD

  Annual Meeting Talks

  2022

• 

  Expert Panel: Sustainability

  Geoffrey G. Emerson, MD, PhD, FASRS

  Jacob D. Grodsky, MD

  David R Anderson, MD, PharmD

  Scott M McClintic, MD

  Annual Meeting Talks

  2024

• 

  Inhibition of Complement C3 in GA with NGM621: Phase 1 Study Results

  David A. Eichenbaum, MD, FASRS

  Updates from the Field

  2021